Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in wilms’ tumor

Journal of Pediatric Surgery

Volumn 35, Issue 12, 2000, Pages 1749-1753

  Karth, John ^a   Ferrer, Fernando A ^a   Perlman, Elizabeth ^a   Hanrahan, Collen ^a   Simons, Jonathan W ^a   Gearhart, John P ^a   Rodriguez, Ronald ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxia inducible factor; Vascular endothelial growth factor; Wilms' tumor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ARTICLE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; STAINING; TUMOR VASCULARIZATION;

EID: 0033668677     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2000.19241     Document Type: Article

References (16)

1. HIF-1 alpha is required for solid tumor formation and embryonic vascularization
2. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
3. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
4. Role of HIF-1 alpha in hypoxia-mediated apoptosis cell proliferation and tumour angiogenesis
5. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases
6. The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities
7. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor
8. Pathological angiogenesis in a murine model of human Wilms' tumor
9. Long-term complications and post-treatment follow-up of patients with Wilms' tumor
10. Tumor-associated angiogenesis: Mechanisms clinical implications and therapeutic strategies
11. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
12. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
13. Increased expression of hypoxia inducible factor-1 alpha in rat and human prostate cancer
14. The biology of vascular endothelial growth factor
15. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
16. Expression of vascular endothelial growth factor receptors in human prostate cancer